Yong-Tang Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yong-Tang Wang has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
Sen Li
17 shared publications- Xiu-Min Lu
College of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, 400054, China
17 shared publications Hai-Yan Wang
15 shared publicationsZai-Yun Long
State Key Laboratory of Trauma and Chemical Poisoning, Daping Hospital, Army Medical University, Chongqing 400042, China
12 shared publicationsXiu-Min Lu
10 shared publicationsCan Tang
College of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China
7 shared publications
Latest Publications
- 14 August 2026
- Published by Elsevier in Cryobiology
- Vol. 124
Cold exposure induced cognitive impairment: A systematic review
- 14 August 2026
- Published by Elsevier in Cryobiology
- Vol. 124
Cold exposure induced cognitive impairment: A systematic review
- 23 January 2026
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 260, 174157
The role of short-chain fatty acids and neuroinflammation in PTSD pathogenesis: A gut microbial perspective
- 23 January 2026
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 260, 174157
The role of short-chain fatty acids and neuroinflammation in PTSD pathogenesis: A gut microbial perspective
- Open Access
- 21 January 2026
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 58 (1) , 211-226
The therapeutic potential and mechanisms of targeting the PTBP1/Nogo-A/NgR axis in PTSD induced by single prolonged stress in mice
The pathophysiology of post-traumatic stress disorder (PTSD) shows notable associations with compromised hippocampal neurophysiology. Notwithstanding ongoing debates, PTBP1 knockdown (KD) demonstrates the capacity to drive glia-to-neuron reprogramming, potentially offering therapeutic benefits for some neurodegenerative pathologies. However, PTBP1 KD can upregulate the expression of Nogo-A by alternative splicing, triggering the inhibition of nerve regeneration. Currently, the role of PTBP1 in PTSD remains unknown. Here we sought to elucidate the neurorestorative effects of modulating the PTBP1/Nogo-A/NgR axis in a mouse model of PTSD established through the single prolonged stress paradigm, and the mechanisms were further investigated through a series of experiments including pathological and molecular detection. The results indicated that PTBP1 KD ameliorates PTSD-like behaviors in mice by balancing Bcl-2/Bax expression and suppressing Caspase-3 splicing activation to inhibit hippocampal neuronal apoptosis, enhancing synaptic plasticity through upregulating PSD95 and SYN1, increasing dendritic spine density and stabilizing axonal architecture via elevated NF200 expression. However, compared with single prolonged stress alone, PTBP1 KD potentiates the activation of Nogo-A/NgR pathway, adversely impacting both dendritic morphology and axonal elongation. Therefore, we proposed a combined KD of PTBP1 and NgR to counteract the adverse effects mediated by Nogo-A signal activation, effectively promoting dendritic growth and axonal extension in hippocampal neurons of PTSD mice. Our findings underscore the potential and limitations of PTBP1 as a therapeutic target and propose a novel method for PTSD treatment through combined target intervention of PTBP1 and NgR. This study provides a theoretical foundation for multitarget intervention strategies in the treatment of PTSD and related disorders.
- 21 January 2026
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 58 (1) , 211-226
Open AccessThe therapeutic potential and mechanisms of targeting the PTBP1/Nogo-A/NgR axis in PTSD induced by single prolonged stress in mice
The pathophysiology of post-traumatic stress disorder (PTSD) shows notable associations with compromised hippocampal neurophysiology. Notwithstanding ongoing debates, PTBP1 knockdown (KD) demonstrates the capacity to drive glia-to-neuron reprogramming, potentially offering therapeutic benefits for some neurodegenerative pathologies. However, PTBP1 KD can upregulate the expression of Nogo-A by alternative splicing, triggering the inhibition of nerve regeneration. Currently, the role of PTBP1 in PTSD remains unknown. Here we sought to elucidate the neurorestorative effects of modulating the PTBP1/Nogo-A/NgR axis in a mouse model of PTSD established through the single prolonged stress paradigm, and the mechanisms were further investigated through a series of experiments including pathological and molecular detection. The results indicated that PTBP1 KD ameliorates PTSD-like behaviors in mice by balancing Bcl-2/Bax expression and suppressing Caspase-3 splicing activation to inhibit hippocampal neuronal apoptosis, enhancing synaptic plasticity through upregulating PSD95 and SYN1, increasing dendritic spine density and stabilizing axonal architecture via elevated NF200 expression. However, compared with single prolonged stress alone, PTBP1 KD potentiates the activation of Nogo-A/NgR pathway, adversely impacting both dendritic morphology and axonal elongation. Therefore, we proposed a combined KD of PTBP1 and NgR to counteract the adverse effects mediated by Nogo-A signal activation, effectively promoting dendritic growth and axonal extension in hippocampal neurons of PTSD mice. Our findings underscore the potential and limitations of PTBP1 as a therapeutic target and propose a novel method for PTSD treatment through combined target intervention of PTBP1 and NgR. This study provides a theoretical foundation for multitarget intervention strategies in the treatment of PTSD and related disorders.
- 3 April 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 308 (Pt 4) , 142770
Deletion of p75NTR rescues behavioral and cognitive dysfunction in SPS-induced PTSD mice through hippocampal PI3K/Akt/mTOR pathway
- 3 April 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 308 (Pt 4) , 142770
Deletion of p75NTR rescues behavioral and cognitive dysfunction in SPS-induced PTSD mice through hippocampal PI3K/Akt/mTOR pathway
- 23 February 2025
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 231, 136-152
Chlorogenic acid improves SPS-induced PTSD-like behaviors in rats by regulating the crosstalk between Nrf2 and NF-κB signaling pathway
- 23 February 2025
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 231, 136-152
Chlorogenic acid improves SPS-induced PTSD-like behaviors in rats by regulating the crosstalk between Nrf2 and NF-κB signaling pathway
- 22 January 2025
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 480 (6) , 3399-3411
Synaptic-mitochondrial transport: mechanisms in neural adaptation and degeneration
Synaptic plasticity is the basis for the proper functioning of the central nervous system. Synapses are the contact points between neurons and are crucial for information transmission, the structure and function of synapses change adaptively based on the different activities of neurons, thus affecting processes such as learning, memory, and neural development and repair. Synaptic activity requires a large amount of energy provided by mitochondria. Mitochondrial transport proteins regulate the positioning and movement of mitochondria to maintain normal energy metabolism. Recent studies have shown a close relationship between mitochondrial transport proteins and synaptic plasticity, providing a new direction for the study of adaptive changes in the central nervous system and new targets for the treatment of neurodegenerative diseases.
- 22 January 2025
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 480 (6) , 3399-3411
Synaptic-mitochondrial transport: mechanisms in neural adaptation and degeneration
Synaptic plasticity is the basis for the proper functioning of the central nervous system. Synapses are the contact points between neurons and are crucial for information transmission, the structure and function of synapses change adaptively based on the different activities of neurons, thus affecting processes such as learning, memory, and neural development and repair. Synaptic activity requires a large amount of energy provided by mitochondria. Mitochondrial transport proteins regulate the positioning and movement of mitochondria to maintain normal energy metabolism. Recent studies have shown a close relationship between mitochondrial transport proteins and synaptic plasticity, providing a new direction for the study of adaptive changes in the central nervous system and new targets for the treatment of neurodegenerative diseases.
- 9 December 2024
- Published by Elsevier in Brain Research
- Vol. 1850, 149392
The effects and possible mechanisms of whole-body vibration on cognitive function: A narrative review
- 9 December 2024
- Published by Elsevier in Brain Research
- Vol. 1850, 149392
The effects and possible mechanisms of whole-body vibration on cognitive function: A narrative review
- 30 October 2024
- Published by Elsevier in Life Sciences
- Vol. 358, 123175
p75NTR mediated chronic restraint stress-induced depression-like behaviors in mice via hippocampal mTOR pathway
- 30 October 2024
- Published by Elsevier in Life Sciences
- Vol. 358, 123175
p75NTR mediated chronic restraint stress-induced depression-like behaviors in mice via hippocampal mTOR pathway
- 22 December 2023
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 82 (2) , 329-342
Single-Cell Sequencing Technology and Its Application in the Study of Central Nervous System Diseases
The mammalian central nervous system consists of a large number of cells, which contain not only different types of neurons, but also a large number of glial cells, such as astrocytes, oligodendrocytes, and microglia. These cells are capable of performing highly refined electrophysiological activities and providing the brain with functions such as nutritional support, information transmission and pathogen defense. The diversity of cell types and individual differences between cells have brought inspiration to the study of the mechanism of central nervous system diseases. In order to explore the role of different cells, a new technology, single-cell sequencing technology has emerged to perform specific analysis of high-throughput cell populations, and has been continuously developed. Single-cell sequencing technology can accurately analyze single-cell expression in mixed-cell populations and collect cells from different spatial locations, time stages and types. By using single-cell sequencing technology to compare gene expression profiles of normal and diseased cells, it is possible to discover cell subsets associated with specific diseases and their associated genes. Therefore, scientists can understand the development process, related functions and disease state of the nervous system from an unprecedented depth. In conclusion, single-cell sequencing technology provides a powerful technology for the discovery of novel therapeutic targets for central nervous system diseases.
- 22 December 2023
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 82 (2) , 329-342
Single-Cell Sequencing Technology and Its Application in the Study of Central Nervous System Diseases
The mammalian central nervous system consists of a large number of cells, which contain not only different types of neurons, but also a large number of glial cells, such as astrocytes, oligodendrocytes, and microglia. These cells are capable of performing highly refined electrophysiological activities and providing the brain with functions such as nutritional support, information transmission and pathogen defense. The diversity of cell types and individual differences between cells have brought inspiration to the study of the mechanism of central nervous system diseases. In order to explore the role of different cells, a new technology, single-cell sequencing technology has emerged to perform specific analysis of high-throughput cell populations, and has been continuously developed. Single-cell sequencing technology can accurately analyze single-cell expression in mixed-cell populations and collect cells from different spatial locations, time stages and types. By using single-cell sequencing technology to compare gene expression profiles of normal and diseased cells, it is possible to discover cell subsets associated with specific diseases and their associated genes. Therefore, scientists can understand the development process, related functions and disease state of the nervous system from an unprecedented depth. In conclusion, single-cell sequencing technology provides a powerful technology for the discovery of novel therapeutic targets for central nervous system diseases.
- 22 September 2023
- Published by Elsevier in Neuropharmacology
- Vol. 240, 109728
Effects and mechanisms of salidroside on the behavior of SPS-induced PTSD rats
- 22 September 2023
- Published by Elsevier in Neuropharmacology
- Vol. 240, 109728
Effects and mechanisms of salidroside on the behavior of SPS-induced PTSD rats